AstraZeneca faces a woman’s recent Nexium and chronic kidney disease lawsuit alleging the acid reflux medication caused complications beyond what she was led to expect.

Plaintiff Yolanda S. files her Nexium and chronic kidney disease lawsuit in the U.S. District Court for the district of New Jersey, joining thousands of other claims in a growing multidistrict litigation (MDL) against the company.

According to the Nexium chronic kidney disease lawsuit, Yolanda says that she took Nexium between 2006 and 2016. However, she states that due to taking the medication she suffered and was eventually diagnosed with chronic kidney disease (CKD).

Her Nexium and chronic kidney disease lawsuit was filed on multiple counts including strict product liability, design defect, failure to warn, negligence, negligence per se, breach of express warranty, breach of implied warranty, negligent misrepresentation, fraud and fraudulent misrepresentation, fraudulent concealment, and Violation of State Consumer Protection Laws of the State of New Jersey, Delaware, and Nevada.

Yolanda demands a trial by jury.

Overview: Nexium and Chronic Kidney Disease

Nexium (esomeprazole) is a proton pump inhibitor (PPI) that functions to reduce the amount of acid produced by the stomach. Nexium can be prescribed to treat conditions such as peptic ulcer disease; gastroesophageal reflux disease (GERD); and Zollinger-Ellison syndrome. It is also prescribed to treat inflammation of the esophagus, known as esophagitis.

While Nexium is thought to help reduce stomach acid production, there have been an increasing number of adverse side effects and complications linked to the medication. Common side effects have included diarrhea, nausea, vomiting, stomach pain, gas, constipation, headaches, drowsiness, dry mouth, rash, and dizziness. Hundreds of injury reports have also been filed with the U.S. Food and Drug Administration (FDA).

However, other more dangerous side effects have also been linked to Nexium, such as serious risk for its causing kidney injury. Complaints have ranged from chronic kidney disease (CKD) and acute kidney injury, to acute interstitial nephritis and renal/kidney failure.

Unfortunately, consumers continue to be severely adversely affected by Nexium, and may say it’s due to the company’s failure to take action and warn consumers of these risks.

A study published in the Journal of the American Society of Nephrology associated Nexium and other PPI medications with severe kidney side effects and complications. The study compared patients taking PPIs to others who took alternate forms of medications known as H2 receptor blockers.

The study reported that patients who were prescribed PPIs, such as Nexium, Prilosec or Prevacid, were more likely to develop adverse kidney complications. It further reported that patients taking PPIs had a 96 percent chance of developing kidney failure with an additional 28 percent chance of developing chronic kidney disease.

The Nexium and Chronic Kidney Disease Lawsuit is Case No. 2:18-cv-16952-CCC-MF, in the U.S. District Court for the District of New Jersey. The Nexium MDL is No. 2789 in re: Proton Pump Inhibitor Products Liability Litigation (No. II), in the U.S. District Court for the District of New Jersey.